4kvp Citations

Structures of oncogenic, suppressor and rescued p53 core-domain variants: mechanisms of mutant p53 rescue.

Acta Crystallogr D Biol Crystallogr 69 2146-56 (2013)
Related entries: 4lo9, 4loe, 4lof

Cited: 10 times
EuropePMC logo PMID: 24100332

Abstract

To gain insights into the mechanisms by which certain second-site suppressor mutations rescue the function of a significant number of cancer mutations of the tumor suppressor protein p53, X-ray crystallographic structures of four p53 core-domain variants were determined. These include an oncogenic mutant, V157F, two single-site suppressor mutants, N235K and N239Y, and the rescued cancer mutant V157F/N235K/N239Y. The V157F mutation substitutes a smaller hydrophobic valine with a larger hydrophobic phenylalanine within strand S4 of the hydrophobic core. The structure of this cancer mutant shows no gross structural changes in the overall fold of the p53 core domain, only minor rearrangements of side chains within the hydrophobic core of the protein. Based on biochemical analysis, these small local perturbations induce instability in the protein, increasing the free energy by 3.6 kcal mol(-1) (15.1 kJ mol(-1)). Further biochemical evidence shows that each suppressor mutation, N235K or N239Y, acts individually to restore thermodynamic stability to V157F and that both together are more effective than either alone. All rescued mutants were found to have wild-type DNA-binding activity when assessed at a permissive temperature, thus pointing to thermodynamic stability as the critical underlying variable. Interestingly, thermodynamic analysis shows that while N239Y demonstrates stabilization of the wild-type p53 core domain, N235K does not. These observations suggest distinct structural mechanisms of rescue. A new salt bridge between Lys235 and Glu198, found in both the N235K and rescued cancer mutant structures, suggests a rescue mechanism that relies on stabilizing the β-sandwich scaffold. On the other hand, the substitution N239Y creates an advantageous hydrophobic contact between the aromatic ring of this tyrosine and the adjacent Leu137. Surprisingly, the rescued cancer mutant shows much larger structural deviations than the cancer mutant alone when compared with wild-type p53. These suppressor mutations appear to rescue p53 function by creating novel intradomain interactions that stabilize the core domain, allowing compensation for the destabilizing V157F mutation.

Reviews - 4kvp mentioned but not cited (1)

  1. Structural and Drug Targeting Insights on Mutant p53. Gomes AS, Ramos H, Inga A, Sousa E, Saraiva L. Cancers (Basel) 13 3344 (2021)

Articles - 4kvp mentioned but not cited (5)

  1. Structures of oncogenic, suppressor and rescued p53 core-domain variants: mechanisms of mutant p53 rescue. Wallentine BD, Wang Y, Tretyachenko-Ladokhina V, Tan M, Senear DF, Luecke H. Acta Crystallogr D Biol Crystallogr 69 2146-2156 (2013)
  2. Tumorigenic p53 mutants undergo common structural disruptions including conversion to α-sheet structure. Bromley D, Daggett V. Protein Sci 29 1983-1999 (2020)
  3. The Pharmacological Mechanism of Xiyanping Injection for the Treatment of Novel Coronavirus Pneumonia (COVID-19): Based on Network Pharmacology Strategy. Xia LJ, Zhang LM, Yang K, Chen T, Ye XW, Yan ZJ. Evid Based Complement Alternat Med 2022 9152201 (2022)
  4. Insights into Allosteric Mechanisms of the Lung-Enriched p53 Mutants V157F and R158L. Lei J, Li X, Cai M, Guo T, Lin D, Deng X, Li Y. Int J Mol Sci 23 10100 (2022)
  5. Structome: a tool for the rapid assembly of datasets for structural phylogenetics. Malik AJ, Langer D, Verma CS, Poole AM, Allison JR. Bioinform Adv 3 vbad134 (2023)


Reviews citing this publication (2)

  1. The p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches. Joerger AC, Fersht AR. Annu Rev Biochem 85 375-404 (2016)
  2. Targeting p53 pathways: mechanisms, structures, and advances in therapy. Wang H, Guo M, Wei H, Chen Y. Signal Transduct Target Ther 8 92 (2023)

Articles citing this publication (2)

  1. Mechanistic insights into global suppressors of protein folding defects. Chattopadhyay G, Bhowmick J, Manjunath K, Ahmed S, Goyal P, Goyal P, Varadarajan R. PLoS Genet 18 e1010334 (2022)
  2. Comparative Study Mutantelec: An In Silico mutation simulation platform for comparative electrostatic potential profiling of proteins. Valdebenito-Maturana B, Reyes-Suarez JA, Henriquez J, Holmes DS, Quatrini R, Pohl E, Arenas-Salinas M. J Comput Chem 38 467-474 (2017)